Slide 1: Welcome to the 3Q25 webinar
Welcome to the 3Q25 webinar October 24, 2025
Slide 2: Today's agenda
Today’s agenda ▪ Q3 in nutshell ▪ Financial highlights ▪ R&D pipeline progress ▪ Update on strategic programs / ESG ▪ Outlook ▪ Summary ▪ Q&A
Slide 3: Modulight
modulight
Slide 4: We fight cancer with science and technology
This is Modulight We fight cancer with science and technology ▪ We are a biomedical company ▪ We also manufacture products that designs and manufactures for other high-value applications laser devices for the treatment such as flow cytometry, quantum of cancer and eye diseases and computing and digi
Slide 5: Q3 in brief
Q3 in brief ▪ Sales & EBITDA improve according to the strategy now four quarters straight ▪ Projects in the pipeline progressing and customer basis & product mix continues to diversify ▪ Customer activity & feedback about product Revenue increased by platform 176% compared to the ▪ Cost savings & in
Slide 6: Financial highlights Jul-Sep 2025
Financial highlights Jul-Sep 2025 ▪ Revenue was 176% higher than in the corresponding period of 2024 ▪ Wider customer base and accumulated backlog enabled growth ▪ PPT business progressing in terms of number of indications and sites Revenue EBITDA EBIT ▪ Product platforms are being used with increas
Slide 7: Financial highlights Jan–Sep 2025
Financial highlights Jan–Sep 2025 ▪ Revenue was 100% higher than in the corresponding period of 2024 ▪ Wider customer base enabled growth despite delays caused by Revenue EBITDA EBIT third parties ▪ PPT business model continues to diversify (customers, indications & #sites) EUR EUR EUR ▪ Order intak
Slide 8: Key figures
Key figures Group EUR 1,000 unless otherwise noted 7–9/2025 7-9/2024 1–9/2025 1-9/2024 1–12/2024 1) Revenue 1,765 640 5,333 2,664 4,095 EBITDA -184 -1,278 -810 -3,813 -4,836 EBITDA - % -10.5 % -199.6 % -15.2 % -143.1 % -118.1% Operating result (EBIT) -1,220 -2,108 -3,861 -6,134 -8,337 Operating resu
Slide 9: Growth in the R&D pipeline
Growth in the R&D pipeline ▪ R&D pipeline remained at 32 (30) projects – aim in all projects is to Number of projects with commercialization potential commercialize our own products ▪ PPT sites at 60 – certain products now 35 show annualized revenue that correspond to value of the install base 30 wi
Slide 10: Modulight's customer base
Modulight’s customer base Customer maturity Customer ownership continues to improve 35 30 ▪ 35% have over 1bn revenue ▪ 60% of customers are listed 25 companies ▪ 60% are established companies 20 ▪ 34% are privately owned 15 ▪ 6% are research companies 10 5 0 2Q22 3Q22 4Q22 1Q23 2Q23 3Q23 4Q23 1Q24
Slide 11: ESG update – Carbon neutral operations
ESG update – Carbon neutral operations ▪ Same core principles and practices throughout our 25 years history ▪ Carbon neutrality in own operations (Scopes 1-2) ▪ Environmental responsibility has been at core focus during current strategy period – emissions from own operations has decreased by 77% fro
Slide 12: Outlook
Outlook Most of Modulight’s customer projects are various types in the early stages of development. These projects are focused on commercializing Modulight’s own products. In line with its strategy, Modulight is also transitioning from device delivery- based payments to a new treatment-session-based
Slide 13: Summary
Summary ▪ Sales growth Q3: +176% YTD: +100% ▪ EBITDA Q3: -183k (-1,278k) YTD: -810k (-3,813k) ▪ Orderbook and customer base continues to diversify ▪ Projects in the pipeline progressing and customer basis & product mix continues to diversify ▪ Customer activity & feedback about product platform ▪ Co
Slide 14: Thank you! Questions?
Thank you! Questions?